Northern Trust’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $36.4M | Sell |
3,233,214
-68,085
| -2% | -$767K | 0.01% | 1289 |
|
|
2025
Q1 | $33.3M | Sell |
3,301,299
-146,783
| -4% | -$1.48M | ﹤0.01% | 1329 |
|
|
2024
Q4 | $40.8M | Buy |
3,448,082
+652,615
| +23% | +$7.72M | 0.01% | 1249 |
|
|
2024
Q3 | $32.3M | Buy |
2,795,467
+402,326
| +17% | +$4.64M | 0.01% | 1318 |
|
|
2024
Q2 | $25.3M | Buy |
2,393,141
+727,806
| +44% | +$7.69M | ﹤0.01% | 1409 |
|
|
2024
Q1 | $17.6M | Buy |
1,665,335
+185,791
| +13% | +$1.96M | ﹤0.01% | 1674 |
|
|
2023
Q4 | $16.6M | Buy |
1,479,544
+30,301
| +2% | +$340K | ﹤0.01% | 1745 |
|
|
2023
Q3 | $16.9M | Buy |
1,449,243
+565,049
| +64% | +$6.6M | ﹤0.01% | 1663 |
|
|
2023
Q2 | $8.91M | Buy |
884,194
+455,564
| +106% | +$4.59M | ﹤0.01% | 2144 |
|
|
2023
Q1 | $3.16M | Buy |
428,630
+30,915
| +8% | +$228K | ﹤0.01% | 2724 |
|
|
2022
Q4 | $3.18M | Buy |
397,715
+101,800
| +34% | +$813K | ﹤0.01% | 2750 |
|
|
2022
Q3 | $953K | Buy |
295,915
+29,805
| +11% | +$96K | ﹤0.01% | 3315 |
|
|
2022
Q2 | $1.08M | Buy |
266,110
+100,597
| +61% | +$409K | ﹤0.01% | 3326 |
|
|
2022
Q1 | $818K | Sell |
165,513
-2,831
| -2% | -$14K | ﹤0.01% | 3526 |
|
|
2021
Q4 | $1.7M | Buy |
+168,344
| New | +$1.7M | ﹤0.01% | 3306 |
|